It may be possible to identify which pre-cancerous cells will develop into a rare type of blood cancer, due to new research ...

Brazilian researchers have developed an electrochemical sensor that can detect pancreatic cancer in its early stages. The ...

Results consistent with pre-clinical studies demonstrating that, in the early stages of the neurodegenerative process, disease progression in the ...

In the past decade, immune checkpoint inhibitors (ICIs) have dramatically changed cancer treatment, significantly improving ...

To ensure a robust domestic supply chain in the U.S., Lawrence Livermore National Laboratory (LLNL) scientists are using ...

Infectious diseases contribute substantially to morbidity and mortality in both developing and developed regions worldwide. Delays in diagnosis remain a ...

Genetics may only partially determine a newborn’s risk of developing Type 1 diabetes. Screening umbilical cord blood could ...

GEn1E Lifesciences Inc., a Phase 2 clinical-stage biotechnology company advancing AI-driven novel precision medicines for immunology, inflammation, and rare diseases, today announced a strategic ...

A new meeting report was published in Volume 18 of Aging-US on April 6, 2026, titled “Toward actionable interventions in ...

ViewsML, a company building the computational layer for biomarker discovery by transforming tissue analysis from a lab process into software, today announced the completion of an oversubscribed $4.9M ...

Biomarkers are redefining how oncology trials are designed, shifting from single-mutation targeting to comprehensive genomic ...

Inflammation research sits at the intersection of immunology, systems biology, and molecular medicine, focusing on the cellular and molecular mechanisms ...